Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION

No-Receipt date 2024-00423 - 30/01/2024
No-Filing date 20240400268 - 30/01/2024
No-Granting date 3114559 - 05/02/2024
No-EPO application date 19718531.7 - 03/04/2019
No-EPO granting date 3773589 - 01/11/2023
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 2/2024 - 12/03/2024
Expiration date 04/04/2039
Kind of title Validation of European Patent
Legal status VALID
Priorities US201862652284 P03/04/2018/US
US201862656297 P11/04/2018/US
US201862657605 P13/04/2018/US
US201862741683 P05/10/2018/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/506
A61K 45/06
A61P 35/00
A61P 35/04

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1576945 BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREETCAMBRIDGE, MA 02139 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
4100726 EVANS RAAB, ERICA
4100727 WOLF, BENI B.

Representatives
CodeFirstnameSurnameAddressTownZip
3463MARIAATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"KOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history 7 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015